open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Abortion

BBC’s “A World Without Down Syndrome?” Documentary Challenges Practice of Disability-Selective Abortion

charlotte-lozier-institute Charlotte Lozier Institute
October 26, 2016
Abstract image showing close-up, spiky, spherical structures in shades of blue and purple, resembling microscopic viruses or cells—evoking themes of ethically non-contentious stem cell research—against a blurred, dark purple background.
Life & the Law

Minnesota’s Funding of Stem Cell Research Echoes Trend toward Ethically Non-Contentious Approaches

In 2014, Minnesota became the most recent of a handful of states that provide state funding for all types of stem cell research, including human embryonic stem cell research (hESCR). The law provides for 10 years of funding with $4.5 million approved for the first year and $4.35 million each year thereafter.

Eugene C. Tarne
October 25, 2016
End of Life

Proposal to Expand Euthanasia in the Netherlands

In 2002, the Netherlands became the first country in the world to decriminalize euthanasia and physician-assisted suicide (PAS) for patients who meet criteria set forth by the law, such as that they endure “unbearable” suffering with “no prospect of improvement.” Now the Dutch government is pushing to expand eligibility to include individuals who have no medical condition but nevertheless feel that their life is completed.

Tim Bradley
October 20, 2016
Cover page of a Charlotte Lozier Institute special report titled Unconscionable: Threats to Religious Freedom and Rights of Conscience in the Abortion Debate by Timothy Bradley, Issue 2, October 2016.
Life & the Law

Unconscionable: Threats to Religious Freedom and Rights of Conscience in the Abortion Debate

Those watching the nation’s capital earlier this year witnessed three important events bearing on religious freedom and rights of conscience in the abortion debate.

Tim Bradley
October 19, 2016
Fact Sheet: Federal Funding Restrictions on Abortion
Life & the Law

Fact Sheet: Federal Funding Restrictions on Abortion

In the years leading up to and following the Supreme Court’s 1973 decision in Roe v. Wade legalizing abortion nationwide, the federal government—primarily Congress—has enacted various measures governing the availability of federal funds for abortion and related services. The Medicaid program, established by President Lyndon Johnson in 1965 to provide health care for low-income Americans, began subsidizing abortions shortly after Roe.

charlotte-lozier-institute Charlotte Lozier Institute
October 13, 2016
Life & the Law

Grants for Stem Cell Research Favor Ethical Approaches

The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013. That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.

Eugene C. Tarne
October 10, 2016
Comments Submitted to Dept. of Health and Human Services on Title X Funding
Life & the Law

Comments Submitted to Dept. of Health and Human Services on Title X Funding

On October 7, the Charlotte Lozier Institute (CLI) filed two separate comments to the Department of Health and Human Services regarding its proposed rule on entities qualifying for the government’s Title X family planning funds. The proposed rule (Compliance with Title X Requirements by Project Recipients in Selecting Subrecipients, 81 FR 61639-61646), which was published September 7, seeks to preclude states from taking action to “restrict participation by certain types of providers as subrecipients in the Title X Program…”

charlotte-lozier-institute Charlotte Lozier Institute
October 7, 2016
Maternal & Public Health

Protecting Life, Not Punishing Women

Some abortion advocates claim that pro-lifers want to punish women seeking abortion. They argue that women were punished for having abortions before Roe v. Wade was decided by the Supreme Court in 1973, and that if Roe is repealed women will once again be subject to punishment.

Tim Bradley
October 6, 2016

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image